Lyra Therapeutics, Inc. (LYRA) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Lyra Therapeutics, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Lyra Therapeutics, Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Continuing Negative
CHATGPT
Turned Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Lyra Therapeutics, Inc. actually do?
Answer:
Lyra Therapeutics is a clinical-stage biotechnology company that historically focused on developing anti-inflammatory therapies for chronic rhinosinusitis (CRS). The company's lead product candidate, LYR-210, a bioabsorbable nasal implant designed to deliver anti-inflammatory drugs for six months, showed mixed results in Phase 3 trials. Following the failure of its ENLIGHTEN 1 trial to meet its primary endpoint, Lyra Therapeutics announced a significant workforce reduction and paused development of LYR-210 and LYR-220. The company has since suspended further development of LYR-210 and is exploring strategic alternatives. Trading of its common stock was suspended, and it was delisted from The Nasdaq Capital Market in March 2026.
Question:
What are Lyra Therapeutics, Inc.'s revenue drivers?
Answer:
To date, Lyra Therapeutics has not generated revenue from product sales. It has recognized collaboration revenue from its LianBio License Agreement, but future revenue is uncertain due to LianBio's wind-down activities.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required